2FDD:
reference: Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385., Miller JF, Andrews CW, Brieger M, Furfine ES, Hale MR, Hanlon MH, Hazen RJ, Kaldor I, McLean EW, Reynolds D, Sammond DM, Spaltenstein A, Tung R, Turner EM, Xu RX, Sherrill RG, Bioorg Med Chem Lett. 2006 Feb 1;. PMID: 16458505

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).